Salute e Benessere

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform

Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform [1]Amsterdam, the Netherlands, and Chicago, USA –Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled BlueSeal Horizon [1], an entirely new 3.0T MRI innovation platform that includes the industry’s first helium-free 3.0T magnet atRSNA 2025. A pivotal advance in MRI innovation, helium-free [2] 3.0T is a major...
Nasdaq GlobeNewswire
30/11/2025

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial…

Attachment Notification of managers' transaction - Arshad Khanani - 25 November 2025 RSU vest
Nasdaq GlobeNewswire
28/11/2025

Medical Membranes Market worth $6.66 billion by 2030 - Exclusive Report by…

260 - Tables 60 - Figures 330 - Pages 260 - Tables 60 - Figures330 - Pages Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=86 The market for medical membranes is driven by the rising global burden of chronic kidney disease, along with the resulting increase in hemodialysis procedures that rely on high-performance dialysis membranes for efficient solute removal and biocompatibility. The geriatric population, the growing number of diabetes cases,...
PR Newswire
28/11/2025

Demonstrating accountability: Zentiva receives prestigious ESG Transparency…

The awards were presented at the ESG Summit 2025, as part of the European Sustainability Week 2025, hosted by the EUPD Group. The recognition is a testament to the efforts of industry leaders who have embedded sustainability in their business strategy and communicate it transparently according to relevant standards. Zentiva received recognition at the Excellence Level of the ESG Transparency Award 2025 for its high degree of clarity, accessibility and transparency in sustainability...
PR Newswire
28/11/2025

Boehringer Ingelheim announces appointment to Board of Managing Directors

Harsha Deshmukh has been appointed a member of the Board of Managing Directors with responsibility for IT and Global Business Services effective 1 February 2026 Boehringer Ingelheim announced today that the Shareholders’ Committee has appointed Harsha Deshmukh to the Board of Managing Directors. Effective 1 February 2026, Harsha Deshmukh will lead the IT and Global Business Services functions focusing on digital transformation and driving the further development of business...
Nasdaq GlobeNewswire
28/11/2025

Tianlong Strengthens Transfusion Safety with Innovative Blood Screening…

Ensuring blood safety remains one of the most effective defenses against transfusion-transmitted infections. By enhancing screening accuracy and enabling laboratories to detect HBV, HCV, HIV-1, and HIV-2 during early infection stages, Tianlong supports global public health efforts and reinforces trust in every unit of donated blood. Ensuring blood safety remains one of the most effective defenses against transfusion-transmitted infections. By enhancing screening accuracy and enabling...
PR Newswire
28/11/2025

CRO Industry to Hit USD 127.77 Billion by 2030 Driven by Advanced Clinical Trial…

North America remains the dominant region in the contract research organization industry, driven by a strong pharmaceutical R&D base, high clinical trial volumes, and established regulatory clarity. The region's leadership is further reinforced by the presence of major global CROs offering full-service solutions across multiple therapeutic domains. North America remains the dominant region in the contract research organization industry, driven by a strong pharmaceutical R&D base, high...
PR Newswire
28/11/2025

Invitation to presentation of Sectra's six-month report 2025/2026

Report presentation: 10:00 a.m. (CET) on the same date Report presentation:10:00 a.m. (CET)on the same date To participate, follow the instructions on Sectra's websiteinvestor.sectra.com/q2report2526. The broadcast will be made available on the same webpage after the conference. Participation will take place via Microsoft Teams. Questions can be posed using the chat function or by sending questions in advance via email toinfo.investor@sectra.com. Sectra's financial reporting...
PR Newswire
28/11/2025

Results of the Votes of the Combined Shareholders’ General Meeting of November…

Daix (France), New York City (New York, United States), November 28, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced the results of the votes of its Combined Shareholders’ Meeting. The Combined Shareholders' Meeting was held on Thursday November 27, 2025, at 9 a.m. at Hôtel Villa M, 24-30...
Nasdaq GlobeNewswire
28/11/2025

New number of shares and votes in Systemair Aktiebolag

As of the date of this press release, Systemair holds 640,000 own shares. As of the date of this press release, Systemair holds 640,000 own shares. For more information, please contact:Anders Ulff, CFO, +46 70 577 40 09 This information is information that Systemair Aktiebolag is obliged to make public pursuant to the Swedish Financial Instruments Trading Act. The information was submitted for publication on28 November 2025at 07.00 CET. This information was brought to you by...
PR Newswire
28/11/2025

Zelluna ASA Announces Appointment of Geir Christian Melen as New Chief Financial…

Oslo, Norway, 28 November 2025 – Zelluna (OSE: ZLNA ), a company pioneering allogeneic “off-the-shelf” T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of cancer, today announced the appointment of Geir Christian Melen as new Chief Financial Officer, effective 01 January 2026. Hans Vassgård Eid will be stepping down as CFO of Zelluna ASA from the end of December 2025 and supporting the transition thereafter.“I am very pleased to appoint Geir Christian as our...
Nasdaq GlobeNewswire
28/11/2025

Rhabdomyosarcoma Market is Expected to Rise Throughout Forecast Period…

Rhabdomyosarcoma Market Summary Rhabdomyosarcoma Market Summary Discover the rhabdomyosarcoma new treatment @New Treatments for Rhabdomyosarcoma Key Factors Driving the Growth of the Rhabdomyosarcoma Market Pediatric Prevalence and Clear Clinical Need Rhabdomyosarcoma is the most common soft-tissue sarcoma in children, with a measurable (though rare) incidence that keeps it a distinct clinical priority in pediatric oncology. Genetic Profiling and Risk...
PR Newswire
27/11/2025

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nyxoah to Participate in the Piper Sandler 37 thAnnual Healthcare ConferenceMont-Saint-Guibert, Belgium – 27 November, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the management team will participate in a fireside chat at the Piper Sandler 37 thAnnual Healthcare...
Nasdaq GlobeNewswire
27/11/2025

GENFIT Announces Appointment of new Chief Medical Officer

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), November 27, 2025-GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the appointment of Dr. Pejvack Motlagh, the new Chief Medical Officer of GENFIT.Member of the Executive Committee, Dr. Motlagh will oversee the strategy, direction, and execution of GENFIT’s clinical development plans and lead the...
Nasdaq GlobeNewswire
27/11/2025

Cosmetic Surgery Market is expected to generate a revenue of USD 71.33 Billion…

👉 For a detailed analysis of Industry Trends And Growth Drivers, Explore The Full Cosmetic Surgery Market. 👉For a detailed analysis of Industry Trends And Growth Drivers, Explore The Full Cosmetic Surgery Market . Browse in-depth TOC 202 – Pages 126 – Tables 37 – Figures Global Cosmetic Surgery Market Overview Market Driver 1. Rising Demand for Minimally Invasive Aesthetic Procedures 2. Growing Influence of Social Media and Digital Beauty...
PR Newswire
27/11/2025

Pet DNA Testing Market to Reach $960.7 Million, Globally, by 2034 at 9.3% CAGR…

Request Sample of the Report on Global Pet DNA Testing Market 2034 - https://www.alliedmarketresearch.com/request-sample/A325828 Request Sample of the Report on Global Pet DNA Testing Market 2034 -https://www.alliedmarketresearch.com/request-sample/A325828 Market Introduction The pet DNA testing market encompasses genetic testing kits and services designed to analyze the DNA of companion animals primarily dogs and cats for insights into breed composition, hereditary traits, and...
PR Newswire
27/11/2025

Lateral Flow Assays Market to Soar to $17.44 Billion by 2033 Amid Robust 6.98%…

Download a free sample copy of this research report: Lateral Flow Assays Market Download a free sample copy of this research report:Lateral Flow Assays Market Technological innovation is another key growth driver for the market. Advancements in assay design, signal amplification, and digital integration have enhanced the sensitivity, specificity, and functionality of LFAs. The introduction of smartphone-compatible devices, cloud connectivity, and multiplexing technologies has...
PR Newswire
27/11/2025

Orphan Drugs Market to Surge to USD 486.51 Billion by 2032 as Rare Disease…

Governments across the U.S., EU, Japan, and Asia-Pacific are strengthening rare-disease incentives-fast-track approvals, accelerated pathways, tax credits, market exclusivity, premium pricing-and biopharma innovators are responding with record investments in orphan drug pipelines. Governments across the U.S., EU,Japan, andAsia-Pacificare strengthening rare-disease incentives-fast-track approvals, accelerated pathways, tax credits, market exclusivity, premium pricing-and biopharma...
PR Newswire
27/11/2025

Legend Biotech Awarded 2025 FIBA Foreign Investor of the Year by Flanders…

Recognizes the company’s continued investment and expansion of cell therapy manufacturing and R&D operations in Ghent, reinforcing Flanders’ position as a global biotech hub SOMERSET, N.J. andGHENT, Belgium, Nov.27, 2025(GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that the Company has been awarded Foreign Investor of the Year at the 2025 Flanders International Business Awards (FIBA) hosted by...
Nasdaq GlobeNewswire
27/11/2025

xTool Launches F2 Ultra UV, a True Glass Master and Ultra-Precise Laser

As a true Glass Master, the F2 Ultra UV uses precisely controlled photon energy to form micro-fractures or micro-bubbles within glass, enabling permanent 3D inner engraving with exceptional clarity. Built-in power-compensation and texture-enhancement algorithms ensure uniform 3D depth, crisp contrast, and vivid detail. The system also supports glass surface relief engraving, cutting, and rotary operations, expanding possibilities for décor, personalized gifts, art pieces, and high-end custom…
PR Newswire
27/11/2025

In-Silico Clinical Trials Market Set to Reach USD 6.39 Billion by 2033 as Pharma…

With rising development costs of pharmaceuticals, delayed approvals, protocol failures, and persistent patient-recruitment challenges, in-silico trial (IST) platforms have become essential tools for accelerating evidence generation. They are now widely adopted by pharmaceutical companies, medical device manufacturers, CROs, and academic research institutions seeking to modernize clinical development and enhance decision-making precision. With rising development costs of pharmaceuticals…
PR Newswire
27/11/2025

Intratumoral Cancer Therapies Market to Reach USD 630.7 Million by 2033 as…

The growing clinical validation of intratumoral immunotherapies, including oncolytic viruses, adenoviral gene-delivery platforms, STING agonists, and localized immunomodulators, has significantly accelerated the adoption of this treatment approach. These modalities are being actively advanced for advanced melanoma, head and neck cancers, breast tumors, and other hard-to-treat solid tumors and metastatic lesions, where direct tumor injection can enhance local immune activation and improve…
PR Newswire
27/11/2025

Change of management at NTG Nordic Transport Group A/S

Company announcement no. 11 – 25 27 November 2025 Change of management at NTG Nordic Transport Group A/S Appointment of new Group CFO NTG announces the appointment of Tinneke Torpe as the new Group Chief Financial Officer (“CFO”), effective no later than 1 April 2026. Tinneke brings extensive experience in financial leadership roles, most recently serving as CFO at TP Aerospace Group, where she was responsible for Business Finance, Accounting, IT & Digitalisation, and Legal...
Nasdaq GlobeNewswire
27/11/2025

Hair Accessories Market to Reach $57.1 billion, Globally, by 2034 at 8.7% CAGR…

Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A06430 Download Sample Pages of Research Overview:https://www.alliedmarketresearch.com/request-sample/A06430 Market Introduction The hair accessories market encompasses a wide range of fashion and functional products designed to enhance hairstyling, improve grooming convenience, and complement personal aesthetics. These accessories play a vital role in everyday styling as well as...
PR Newswire
27/11/2025
Altri  Comunicati